TAK - Takeda gets FDA approval for eosinophilic esophagitis drug
2024-02-12 14:38:53 ET
More on Takeda Pharmaceutical
- Takeda Pharmaceutical Company Limited 2023 Q3 - Results - Earnings Call Presentation
- Takeda Pharmaceutical Company Limited (TAK) Q3 2023 Earnings Call Transcript
- CRISPR CMO who resigned after Casgevy approval lands at Takeda
- Protagonist Therapeutics stock rises on Takeda license deal
- Seeking Alpha’s Quant Rating on Takeda Pharmaceutical